nAMD Cases & Clinical Conversations - Part 1

nAMD Cases Clinical Conversations Part 1

Media formats available:

Details

Presenters

Overview

This activity, featuring retina specialists from Mayo Clinic, mimics the format of traditional grand rounds. Drs. Barkmeier, Scruggs, and Starr present real-world case studies of patients with neovascular age-related macular degeneration and answer questions from Chair and Professor of Ophthalmology at Mayo Clinic, Sophie J. Bakri, MD. The presentation concludes with a brief presentation by Dr. Bakri.
Learn from the experiences and insights of seasoned professionals while being exposed to a diverse range of cases, evidence-based decision-making, and collaborative problem-solving.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Identify key risk factors and biomarkers that aid early detection and diagnosis of nAMD
- Analyze factors that prevent translation of nAMD clinical trial treatment efficacy into real-world treatment effectiveness
- Evaluate how advances in nAMD treatments could improve real-world patient outcomes
- Debate the clinical significance of different measures of treatment efficacy in nAMD and their real-world utility
- Discuss key considerations that may influence the selection, timing, and execution of treatment plans for patients with nAMD
- Devise effective referral strategies and plans for co-management of nAMD with eye care and non-eye care specialists
Accreditation
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Faculty and Disclosures
Sophie J. Bakri, MD
Chair and Professor of Ophthalmology
Mayo Clinic
Rochester, MN

Andrew J. Barkmeier, MD
Vitreoretinal Surgeon
Mayo Clinic
Rochester, MN

Brittni A. Scruggs, MD, PhD
Adult and Pediatric Vitreoretinal Surgeon
Mayo Clinic
Rochester, MN

Matt Starr, MD
Mayo Clinic
Rochester, MN

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Sophie J. Bakri, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie, Adverum, Allergan, Amgen, Annexon, Apellis Pharmaceuticals, Aviceda, Carl Zeiss Meditec, Cholgene, Eyepoint Pharmaceuticals, Ilumen, Iveric Bio, Kala, Genentech, Neurotech, Novartis, Ocular Therapeutix, Opthea, Outlook, Pixium, Regeneron, Regenxbio, Rejuvitas, Revana, Roche, and VoxelCloud. Grant / Research Support: Lowy Medical Foundation and Regenxbio.
Andrew J. Barkmeier, MD, has had no financial relationships or affiliations with ineligible companies.
Brittni A. Scruggs, MD, PhD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Iveric Bio.
Matt Starr, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Abbvie, Alimera Sciences, Allergan, Gyroscope Therapeutics, and Regenxbio.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Regeneron Pharmaceuticals, Inc.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 09/04/2024
Expiration Date: 09/04/2025

Sophie J. Bakri, MD

Sophie J. Bakri, MD

Andrew J. Barkmeier, MD

Andrew J. Barkmeier, MD

Brittni A. Scruggs, MD, PhD

Brittni A. Scruggs, MD, PhD

Matt Starr, MD

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Overcoming Treatment Plateaus in Chronic DME
Overcoming Treatment Plateaus in Chronic DME
CME/CE
Overcoming Treatment Plateaus in Chronic DME
0.25 credits
- Sunir J. Garg, MD, FACS, FASRS
- Charles C. Wykoff, MD, PhD, FACS
0.25 credits
Retina Specialist Perspectives
Retina Specialist Perspectives
CME/CE
Retina Specialist Perspectives
0.25 credits
- Sunir J. Garg, MD, FACS, FASRS
- Charles C. Wykoff, MD, PhD, FACS
0.25 credits
MinuteCE®
Biomarking the Difference: How Second-Generation Therapies are Changing the Game
1.00 credit 10 episodes
- Justis P. Ehlers, MD, FASRS
- Roger A. Goldberg, MD, MBA
- Jennifer, I. Lim, MD, FASRS, FARVO
- Ehsan Rahimy, MD
1.00 credit 10 episodes
Tracking GA Development: From Initial Symptoms to Treatment Approaches
Tracking GA Development: From Initial Symptoms to Treatment Approaches
CME/CE
Tracking GA Development: From Initial Symptoms to Treatment Approaches
1.00 credit
- Elizabeth (Beth) Richter, MD, PhD
- Julie Rodman, OD, MSc
1.00 credit